The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...

Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus Registry to advance lupus research. The ...

In 2023, the market has already surpassed USD 1,716.5 million, reflecting its steady expansion. Among the key contributors, diagnostic laboratories account for over 51.8% of the market share, ...

This useful study presents findings on the developmental roles of Nup107, a key nucleoporin, in regulating the larval-to-pupal transition in Drosophila melanogaster through its involvement in ecdysone ...

Shares of Thermo Fisher Scientific Inc. TMO shed 1.89% to $523.23 Thursday, on what proved to be an all-around rough trading ...

Thermo Fisher printed a Sfr410m 0.832% September 2026 at 70bp over Saron, alongside a Sfr315m 1.125% March 2029 at 85bp over; ...

Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that the company has entered into a definitive agreement with Solventum  to acquire Solventum’s ...

Jim Cramer was recently asked about Danaher Corporation (NYSE:DHR) on CNBC. Cramer praised the company’s management and said ...

Thermo Fisher Scientific is buying Solventum’s purification & filtration unit for $4.1 billion in cash, strengthening its ...

AbbVie, Danaher, Organovo, Thermo Fisher Scientific, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of ...